PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,850.00
Bid: 1,850.00
Ask: 1,860.00
Change: -30.00 (-1.60%)
Spread: 10.00 (0.541%)
Open: 1,912.00
High: 1,912.00
Low: 1,842.00
Prev. Close: 1,880.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Acquisition of Genetiporc do Brasil

10 Feb 2014 07:00

RNS Number : 6325Z
Genus PLC
10 February 2014
 



For Immediate Release 10 February 2014

 

GENUS plc

 

Completion of Acquisition of Genetiporc do Brasil

 

Genus plc ("Genus" or the "Group"), a leading global animal genetics company, is pleased to confirm that, further to the announcements on 23 September 2013 and 18 October 2013 regarding Genus' acquisition of Génétiporc, Agroceres PIC, Genus' 49% owned joint venture in Brazil, has completed the acquisition of Genetiporc do Brasil LTDA, Génétiporc's Brazilian joint venture. 

 

Genetiporc do Brasil has been acquired for a total purchase price of Real 19m (£4.9m). The acquisition by Agroceres PIC has been funded by Genus and its joint venture partner, Agroceres, subscribing for additional equity pro rata to their existing equity ownership. For the year ending 31 December 2013 Genetiporc do Brasil had a turnover of Real 26.2m (£6.7m) and profit before tax of Real 2.9m (£0.7m).

 

Genetiporc do Brasil represents an excellent strategic fit with Agroceres PIC's core activities and the acquisition will bring significant opportunities from the combination of the two operations and will further strengthen Agroceres PIC's business in Brazil.

 

For further information please contact:

 

Genus plc

Tel: 01256 345970

Karim Bitar, Chief Executive

 

Stephen Wilson, Group Finance Director

 

 

 

 

Buchanan

Tel: 0207 466 5000

Charles Ryland /Sophie McNulty

 

 

This announcement is available on the Genus website www.genusplc.com

 

About Genus

Genus creates advances to animal breeding and genetic improvement by applying biotechnology and sells added value products for livestock farming and food producers. Its technology is applicable across all livestock species and is currently commercialised by Genus in the dairy, beef and pork food production sectors.

 

Genus' worldwide sales are made in seventy countries under the trademarks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. Genus' customers' animals produce offspring with greater production efficiency, and quality, and use these to supply the global dairy and meat supply chain.

 

The Group's competitive edge has been created from the ownership and control of proprietary lines of breeding animals, the biotechnology used to improve them and its global supply chain, technical service and sales and distribution network.

 

With headquarters in Basingstoke, United Kingdom, Genus companies operate in thirty countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

 

About Génétiporc

Génétiporc is the porcine breeding business of Aliments Breton Foods Group. It is based in Canada with operations in the US and Mexico and a joint venture in Brazil.

 

Founded in 1984, in response to demand from producers for a swine genetics company that would understand their concerns and would be there to offer solutions, Génétiporc is now one of the leading providers of porcine genetics in North America and Brazil. It prides itself on its achievements in product development, health and biosecurity and meat quality.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFFDFRIAIIS
Date   Source Headline
28th Jun 20215:00 pmRNSPIC AND SERGAL ENTER INTO STRATEGIC RELATIONSHIP
22nd Jun 20217:00 amRNSCapital Markets Event & PRRSv Programme Update
14th Jun 20213:01 pmRNSNotification of Major Holdings
7th Jun 202110:42 amRNSApplication For Additional Listing
4th Jun 20214:38 pmRNSNotification of Major Holdings
17th May 20211:23 pmRNSNotification of Major Holdings
13th May 202110:50 amRNSDirector/PDMR Shareholding
9th Apr 20214:10 pmRNSDirector/PDMR Shareholding
6th Apr 20216:00 pmRNSDirector/PDMR Shareholding
1st Apr 20215:49 pmRNSTotal Voting Rights
31st Mar 20212:59 pmRNSDirector/PDMR Shareholding
22nd Mar 20217:00 amRNSBoard Changes
19th Mar 202112:20 pmRNSDirector/PDMR Shareholding
9th Mar 20215:41 pmRNSNotification of Major Holdings
3rd Mar 20215:19 pmRNSDirector/PDMR Shareholding
26th Feb 202112:39 pmRNSDirector/PDMR Shareholding
25th Feb 20217:00 amRNSInterim Results
1st Feb 202111:08 amRNSBlock listing Interim Review
1st Feb 202111:08 amRNSTotal Voting Rights
18th Jan 20217:00 amRNSTrading Update
2nd Dec 20205:44 pmRNSDirector/PDMR Shareholding
25th Nov 20201:13 pmRNSResult of AGM
25th Nov 20207:00 amRNSAGM Trading Update - Strong Performance Continues
11th Nov 20201:03 pmRNSNOTIFICATION OF MAJOR HOLDINGS
16th Oct 20208:00 amRNSAnnual Report and Annual General Meeting
1st Oct 20203:45 pmRNSTotal Voting Rights
25th Sep 20206:14 pmRNSDirector/PDMR Shareholding
23rd Sep 20209:35 amRNSDirector/PDMR Shareholding
16th Sep 202012:16 pmRNSDirector/PDMR Shareholding
15th Sep 20205:52 pmRNSDirector/PDMR Shareholding
9th Sep 202012:17 pmRNSNOTIFICATION OF MAJOR HOLDINGS
8th Sep 20203:16 pmRNSApplication for Additional Listing
8th Sep 20207:00 amRNSPreliminary Results
1st Sep 20201:03 pmRNSTotal Voting Rights
3rd Aug 20204:15 pmRNSBlock listing Interim Review
1st Jul 202010:41 amRNSTotal Voting Rights
30th Jun 20203:45 pmRNSNOTIFICATION OF MAJOR HOLDINGS
29th Jun 20207:00 amRNSDirectorate Appointment
14th May 20206:23 pmRNSApplication for Block Listing
1st May 20203:04 pmRNSTotal Voting Rights
30th Apr 202010:24 amRNSCompliance with LR 9.2.6ER(1)
22nd Apr 20205:47 pmRNSDirector/PDMR Shareholding
21st Apr 202012:14 pmRNSNotification of Major Holdings
20th Apr 20209:28 amRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
1st Apr 20205:52 pmRNSTotal Voting Rights
27th Feb 20207:00 amRNSInterim Results
26th Feb 202012:44 pmRNSNOTIFICATION OF MAJOR HOLDINGS
17th Feb 20205:27 pmRNSNotification of Major Holdings
7th Feb 20209:03 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.